Pure Biologics S.A. (WSE:PUR)
Poland
· Delayed Price · Currency is PLN 8.90
-0.20 (-2.20%)
May 13, 2025, 4:46 PM CET
Pure Biologics Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | -19.44 | -35.69 | -25.6 | -11.77 | -11.76 | Upgrade
|
| Depreciation & Amortization | 0.31 | 5.75 | 2.23 | 2.65 | 3.07 | Upgrade
|
| Other Amortization | - | 0.04 | 0.27 | 0.27 | 0.04 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.24 | 0.62 | 0.03 | - | Upgrade
|
| Other Operating Activities | 1.34 | 10.91 | 4.76 | 3.01 | 3.95 | Upgrade
|
| Change in Accounts Receivable | 12.98 | 0.2 | -5.93 | -7.94 | -0.34 | Upgrade
|
| Change in Inventory | - | - | - | - | 0.09 | Upgrade
|
| Change in Unearned Revenue | -4.81 | 1.95 | -0.93 | -8.59 | 4.2 | Upgrade
|
| Change in Other Net Operating Assets | -0.9 | -6.65 | 7.19 | -1.71 | -0.61 | Upgrade
|
| Operating Cash Flow | -10.83 | -23.26 | -17.39 | -24.04 | -1.35 | Upgrade
|
| Capital Expenditures | - | -0.18 | -5.76 | -0.67 | -0.56 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.01 | 0.05 | 0.01 | - | Upgrade
|
| Investment in Securities | - | 0.92 | 21.05 | -27.81 | - | Upgrade
|
| Other Investing Activities | 3.56 | -0.37 | - | - | - | Upgrade
|
| Investing Cash Flow | 3.56 | 0.39 | 15.35 | -28.48 | -0.56 | Upgrade
|
| Long-Term Debt Issued | 4.42 | 12 | - | - | - | Upgrade
|
| Total Debt Issued | 4.42 | 12 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.15 | -3.53 | -1.55 | -2.15 | -2.7 | Upgrade
|
| Total Debt Repaid | -0.15 | -3.53 | -1.55 | -2.15 | -2.7 | Upgrade
|
| Net Debt Issued (Repaid) | 4.27 | 8.47 | -1.55 | -2.15 | -2.7 | Upgrade
|
| Issuance of Common Stock | - | 18.86 | - | 52.11 | - | Upgrade
|
| Other Financing Activities | -0.29 | -3.11 | -0.33 | -0.23 | -0.35 | Upgrade
|
| Financing Cash Flow | 3.98 | 24.22 | -1.88 | 49.74 | -3.05 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | Upgrade
|
| Net Cash Flow | -3.29 | 1.35 | -3.92 | -2.78 | -4.97 | Upgrade
|
| Free Cash Flow | -10.83 | -23.44 | -23.15 | -24.71 | -1.91 | Upgrade
|
| Free Cash Flow Margin | - | -24671.58% | -3496.22% | -9727.56% | -334.62% | Upgrade
|
| Free Cash Flow Per Share | - | -7.35 | -10.27 | -11.12 | -1.16 | Upgrade
|
| Cash Interest Paid | - | 3.11 | 0.33 | 0.23 | 0.35 | Upgrade
|
| Levered Free Cash Flow | 1.43 | -19.14 | -14.08 | -19.85 | 2.22 | Upgrade
|
| Unlevered Free Cash Flow | 2.26 | -16.75 | -13.88 | -19.71 | 2.44 | Upgrade
|
| Change in Net Working Capital | -9.69 | 4.83 | -0.4 | 18.19 | -3.36 | Upgrade
|
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.